Why DNA testing kit makers are investing in China – South China Morning Post
What happened: China’s DNA market is attracting rising investment from equipment makers with applications ranging from cancer detection and treatment to prenatal screening. China’s DNA sequencing market is expected to reach RMB 18.3 billion by 2022.

Why it’s important: China’s growing market in DNA implies a future trend in the country’s biotech markets. According to research, the global DNA sequencing market could reach $22 billion by 2024 and China is expected to grow faster than it due to rising income and growing investments in healthcare infrastructure. Early stage diagnoses and other advancements in the medical field also help to ease the burden of China’s ailing national healthcare system.

Start your free trial now.

Get instant access to all our premium content, archives, newsletters, and online community.

Monthly Membership

Yearly Membership

What you get

Full access to all premium content and our full archives

Members'-only newsletters

Preferential access and discounts to all TechNode events

Direct access to the TechNode newsroom

Start your free trial now.

Get instant access to all our premium content, archives, newsletters, and online community.

Monthly Membership

Yearly Membership

Jiefei Liu

Jiefei Liu is a Beijing based tech reporter. She focuses on the union of tech and content creation and loves agriculture. You can write to her at Jiefei@technode.com